Search

Your search keyword '"Smith, Jaclyn A."' showing total 1,036 results

Search Constraints

Start Over You searched for: Author "Smith, Jaclyn A." Remove constraint Author: "Smith, Jaclyn A."
1,036 results on '"Smith, Jaclyn A."'

Search Results

204. Overview of the Management of Cough: CHEST Guideline and Expert Panel Report

207. Respiratory distress symptom intervention for non-pharmacological management of the lung cancer breathlessness–cough–fatigue symptom cluster: randomised controlled trial

208. Adaptive study design to assess effect of TRPV4 inhibition in patients with chronic cough

210. Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study

211. PAciFy Cough – A multicentre, double blind, placebo controlled, crossover trial of morphine sulfate for the treatment of PulmonAry Fibrosis Cough

216. Global physiology and pathophysiology of cough: Part 1. Cough phenomenology: CHEST Guideline and Expert Panel report

217. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

218. Acute Cough Due to Acute Bronchitis in Immunocompetent Adult Outpatients: CHEST Expert Panel Report

219. Managing Chronic Cough Due to Asthma and NAEB in Adults and Adolescents: CHEST Expert Panel Report

220. Pan-cancer analysis of whole genomes

226. Comorbid Conditions and Medical History Among Patients with Refractory or Unexplained Chronic Cough in Two Phase 3 Clinical Trials (COUGH-1 and COUGH-2)

227. Cough Triggers and Symptoms Among Patients with Refractory or Unexplained Chronic Cough in Two Phase 3 Trials of the P2X3 Receptor Antagonist Gefapixant (COUGH-1 and COUGH-2)

229. Global Physiology and Pathophysiology of Cough

232. Longitudinal assessment of lung clearance index to monitor disease progression in children and adults with cystic fibrosis.

236. Life-Threatening and Non-Life-Threatening Complications Associated With Coughing

238. Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough

239. Late Breaking Abstract - Two Phase 3 Randomized Clinical Trials of Gefapixant, a P2X3 Receptor Antagonist, in Refractory or Unexplained Chronic Cough (COUGH-1 and COUGH-2)

244. Managing Chronic Cough Due to Asthma and NAEB in Adults and Adolescents

246. Acute Cough Due to Acute Bronchitis in Immunocompetent Adult Outpatients

248. Lung clearance index in healthy volunteers, measured using a novel portable system with a closed circuit wash-in

Catalog

Books, media, physical & digital resources